Evidence map›Paper›PMID 35546741›Full record

ArticleMolecular ecology2022

Multi-omics analysis identifies a CYP9K1 haplotype conferring pyrethroid resistance in the malaria vector Anopheles funestus in East Africa.

Jack Hearn, Carlos S Djoko Tagne, Sulaiman S Ibrahim, Billy Tene-Fossog, Leon M J Mugenzi, Helen Irving, Jacob M Riveron, Gareth D Weedall, Charles S Wondji

Open access · hybridAbstract read
In one paragraph

Article in Molecular ecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Synergistic action of different molecular mechanisms causes striking levels of insecticide resistance in the malaria vectorProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Distinct Genetic Footprint of Adaptation Observed WithinResearch and reports in tropical medicine · 2026
    Article
  10. Article
  11. Spatial Heterogeneity ofJournal of parasitology research · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Jack HearnVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID 0000-0003-3358-4949
Carlos S Djoko TagneLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Sulaiman S IbrahimVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID 0000-0003-0744-802X
Billy Tene-FossogLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Leon M J MugenziLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID 0000-0002-6857-9608
Helen IrvingVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Jacob M RiveronVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Gareth D WeedallSchool of Biological and Environmental Sciences, Liverpool John Moores University, Liverpool, UK.ORCID 0000-0002-8927-1063
Charles S WondjiVector Biology Department, Liverpool School of Tropical Medicine, Liverpool, UK.ORCID 0000-0003-0791-3673
Liverpool School of Tropical Medicine · GBMinistry of Scientific Research and Innovation · CMLiverpool John Moores University · GBUniversity of Bamenda · CM

Funding

Wellcome TrustWellcome Trust 101893/Z/13/ZWellcome Trust 217188/Z/19/Z
6 · The paper itself

Abstract

Metabolic resistance to pyrethroids is a menace to the continued effectiveness of malaria vector controls. Its molecular basis is complex and varies geographically across Africa. Here, we used a multi-omics approach, followed-up with functional validation to show that a directionally selected haplotype of a cytochrome P450, CYP9K1 is a major driver of resistance in Anopheles funestus. A PoolSeq GWAS using mosquitoes alive and dead after permethrin exposure, from Malawi and Cameroon, detected candidate genomic regions, but lacked consistency across replicates. Targeted sequencing of candidate resistance genes detected several SNPs associated with known pyrethroid resistance QTLs. The most significant SNPs were in the cytochrome P450 CYP304B1 (Cameroon), CYP315A1 (Uganda) and the ABC transporter gene ABCG4 (Malawi). However, when comparing field resistant mosquitoes to laboratory susceptible, the pyrethroid resistance locus rp1 and SNPs around the ABC transporter ABCG4 were consistently significant, except for Uganda where SNPs in the P450 CYP9K1 was markedly significant. In vitro heterologous metabolism assays with recombinant CYP9K1 revealed that it metabolises type II pyrethroid (deltamethrin; 64% depletion) but not type I (permethrin; 0%), while moderately metabolising DDT (17%). CYP9K1 exhibited reduced genetic diversity in Uganda underlying an extensive selective sweep. Furthermore, a glycine to alanine (G454A) amino acid change in CYP9K1 was fixed in Ugandan mosquitoes but not in other An. funestus populations. This study sheds further light on the evolution of metabolic resistance in a major malaria vector by implicating more genes and variants that can be used to design field-applicable markers to better track resistance Africa-wide.

Indexed as

AnophelesInsecticidesMalariaPyrethrinsAnimalsATP-Binding Cassette TransportersCytochrome P-450 Enzyme SystemHaplotypesInsecticide ResistanceMosquito VectorsPermethrinUgandaATP-Binding Cassette TransportersCytochrome P-450 Enzyme SystemInsecticidesPermethrinPyrethrinsmulti-omicspyrethroid

Identifiers

PMID35546741
PMCPMC9321817
OpenAlexW4280495192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.